Diligence memo · auto-generated · as of July 2, 2026
Credence MedSystems, Inc.
Credence MedSystems, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Credence MedSystems, Inc. operates in Other Health Care, based in MENLO PARK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Credence MedSystems, Inc. has raised $82M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $40M on 2020-04-24.
Most recent recorded round closed around 2024-12-17.
Valuation (modeled)modeled
Provath models Credence MedSystems, Inc. at approximately $72M (range $30M–$118M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.47× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 18 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 2.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).
Modeled value ranks above 73% of those peers.
Closest niche peers: Code Biotherapeutics, Inc., Candesant Biomedical, Inc., Artis Holdings, LLC, GIO Blood Ltd, Clarapath, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.